3,000 patients to help doctors better understand cirrhosis and transplant care
NCT ID NCT06544863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 3,000 adults with cirrhosis or who have had a liver transplant at a French hospital. Researchers will track survival and complications like bleeding or infections to learn how to improve patient care. The goal is to collect data and samples to better understand the disease and develop better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Digestive Surgery Department, Pitié-Salpêtrière Hospital
RECRUITINGParis, 75013, France
-
Intensive Care Unit, Pitié Salpêtrière Hospital
RECRUITINGParis, 75013, France
-
Pitié Salpêtrière University Hospital
RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?